Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 3 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 2 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (3)

Showing 3 of 3 trials
NCT06874673Not ApplicableNot Yet Recruiting

Pronase in Improving Endoscopic Mucosal Clarity During Colonoscopy for Patients with Colitis

Role: collaborator

NCT02946528Not ApplicableCompleted

Urgent-start Peritoneal Dialysis in ESRD Patients：A Multi-center Study

Role: collaborator

NCT04786704Completed

A Stool DNA Test for Detection of Advanced Colorectal Neoplasia in Asymptomatic Chinese Community Population

Role: collaborator

All 3 trials loaded